Brief: PainReform Reaches 50% Enrollment In Second Part Of Its Phase 3 Clinical Trial Of PRF-110 In Bunionectomy
02/04/2024 15:18
April 2 (Reuters) - PainReform Ltd PRFX.O :
* PAINREFORM REACHES 50% ENROLLMENT IN THE SECOND PART OF
ITS
PHASE 3 CLINICAL TRIAL OF PRF-110 IN BUNIONECTOMY
* PAINREFORM LTD - ON TRACK TO WRAP UP ENROLLMENT ON
SCHEDULE AND
ARE LOOKING FORWARD TO SHARING EARLY RESULTS IN Q3 2024
Source text for Eikon: ID:nGNX8L50xY
Further company coverage: PRFX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PRF Technologies
See all newsBrief: Prf Technologies S.H.N. Financial Investments Seeks Special General Meeting At Prf Technologies To Remove Directors, Appoint Three S.H.N. Nominees
U.S. STOCKS ON THE MOVE-Bumble, Tempus AI, TD Synnex
U.S. STOCKS ON THE MOVE-Bio-Techne, IBM, Apple
PRF Technologies rises as animal study shows pain drug matches approved rival
U.S. STOCKS ON THE MOVE-Wendy's, Canadian Solar, Bio-Techne